Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM) -- Ignore unavailable to you. Want to Upgrade?

To: Dick Martin who wrote (517)	9/26/2004 9:59:47 PM
From: Rocket Red	Read Replies (1) \| Respond to of 655

Is the Trout Group still promoting rbm?I see when they did the stock flew and now they have another one CardioComm hires Trout Group for IR services CardioComm Solutions Inc CCG Shares issued 35,491,305 Sep 21 2004 close $ 0.25 Wednesday September 22 2004 News Release Mr. Stephen Martin reports CARDIOCOMM SOLUTIONS INC. ENGAGES THE TROUT GROUP; SPECIALIZED NEW YORK-BASED INVESTOR RELATIONS FIRM TO LEAD U.S. CAPITAL MARKETS ACTIVITY CardioComm Solutions Inc. has engaged the Trout Group LLC, a leading New York-based investor relations firm, to facilitate the company's exposure to United States capital markets by developing relationships with portfolio managers, investment bankers and industry analysts in New York and San Francisco. With extensive institutional investor relationships in the United States, Canada and Europe, the Trout Group provides strategic advisory and investor relations services to life sciences companies. "As we continue to see significant increases in revenue and expand upon key business development partnerships within the United States market, it is important to begin creating American-based investor awareness for our company. We are delighted to be doing so with the Trout Group. We believe that they have the background, industry understanding and the necessary tools to help broaden our message," said Stephen Martin, president and chief executive officer of CardioComm Solutions Inc. Jonathan Fassberg, president of the Trout Group, said: "CardioComm Solutions has impressed us with their technology and business model as well as the partnerships they have with some of the leading cardiology companies in the world. We are excited by the prospect of bringing this highly innovative company to some of the savviest life sciences investors in the United States." Pursuant to the engagement, CardioComm will provide compensation to the Trout Group of $5,000 (U.S.) per month. In addition, subject to regulatory approval, the Trout Group will receive an option to purchase 300,000 common shares of CardioComm Solutions at an exercise price of 23 Canadian cents. About the Trout Group Since 1995, Trout professionals have advised over 100 public and private companies throughout the United States, Canada and Europe, with corporate positioning and strategy development, institutional and retail investor outreach, management, administration and fundraising support, and market intelligence. Headquartered in New York, the Trout Group also serves clients from satellite offices in San Francisco, Boston, Munich and Tel Aviv.